Inventor · disambiguated record
Paul Goldsmith
Also filed as: GOLDSMITH PAUL · GOLDSMITH PAUL K
8 granted patents·19 pending applications·28 citations·filing 2000–2025
79Inventor score
Files withCLOSED LOOP MEDICINE LTD14GOLDSMITH PAUL4ROACH ALAN GEOFFREY3TAKAFUJI VIVIAN2BARRETT RUTH1
Top patents by PatentIndex Score
27 records- 0183US6974698B1Methods for delivering biologically active molecules into cellsUS HEALTH·Filed 2000·Granted Dec 13, 2005·25 cites·3 claims
- 0273US8247183B2Compositions and methods for diagnosis and treatment of tumorsTAKAFUJI VIVIAN·Filed 2010·Granted Aug 21, 2012·2 cites·17 claims
- 0367US2025364101A1Dabigatran DosingCLOSED LOOP MEDICINE LTD·Filed 2025·Application pending·0 cites
- 0463US8658683B2Combination of alpha-2 receptor agonist (clonidin) and anti-muscarinic agent (oxybutynin) for the treatment of sialorrhoeaROACH ALAN GEOFFREY·Filed 2012·Granted Feb 25, 2014·1 cites·19 claims
- 0563US2024274252A1Dosage CalculatorCLOSED LOOP MEDICINE LTD·Filed 2023·Application pending·0 cites
- 0659US12295943B2Apixaban dosingCLOSED LOOP MEDICINE LTD·Filed 2023·Granted May 13, 2025·0 cites·15 claims
- 0758US2025195486A1Edoxaban dosingCLOSED LOOP MEDICINE LTD·Filed 2023·Application pending·0 cites
- 0858US2025177407A1Rivaroxaban DosingCLOSED LOOP MEDICINE LTD·Filed 2023·Application pending·0 cites
- 0957US12420014B2Dosing of incretin pathway drugsCLOSED LOOP MEDICINE LTD·Filed 2024·Granted Sep 23, 2025·0 cites·24 claims
- 1057US2022328191A1Methods and Systems for Providing Personalised Medicine to a PatientCLOSED LOOP MEDICINE LTD·Filed 2022·Application pending·0 cites
- 1156US2023386636A1Treatment SupportCLOSED LOOP MEDICINE LTD·Filed 2023·Application pending·0 cites
- 1255US2023317230A1Method for treating obesityCLOSED LOOP MEDICINE LTD·Filed 2023·Application pending·0 cites
- 1354US8568977B2Compositions and methods for diagnosis and treatment of tumorsTAKAFUJI VIVIAN·Filed 2012·Granted Oct 29, 2013·0 cites·12 claims
- 1454US2024226013A9Formulation of a multi layered pellet comprising melatoninCLOSED LOOP MEDICINE LTD·Filed 2022·Application pending·0 cites
- 1552US11710547B2Methods and systems for providing personalised medicine to a patientCLOSED LOOP MEDICINE LTD·Filed 2020·Granted Jul 25, 2023·0 cites·23 claims
- 1651US8481583B2Combination of alpha-2 receptor agonist (clonidin) and anti-muscarinic agent (oxybutynin) for the treatment of sialorrhoeaROACH ALAN GEOFFREY·Filed 2007·Granted Jul 9, 2013·0 cites·6 claims
- 1751US2023181551A1Dosage regimen of amlodipineCLOSED LOOP MEDICINE LTD·Filed 2021·Application pending·0 cites
- 1846US2006115895A1Fish disease models and uses thereofGOLDSMITH PAUL·Filed 2003·Application pending·0 cites
- 1941US2007174925A1Treatment models and uses thereofBARRETT RUTH·Filed 2004·Application pending·0 cites
- 2041US2010184727A1Treatment of excess sebum productionSUMMIT CAMBRIDGE LTD·Filed 2007·Application pending·0 cites
- 2141US2006233709A1Method for identifying novel treatments of inflammatory disease in the gutGOLDSMITH PAUL·Filed 2004·Application pending·0 cites
- 2240US2006150259A1Model of bone disease amenable to high-throughput screeningGOLDSMITH PAUL·Filed 2004·Application pending·0 cites
- 2339US2005015823A1Screening methods employing fish model assessment of visionFiled 2002·Application pending·0 cites
- 2438US2010298282A1Treatment of Ocular Conditions and the Side-Effects of GlucocorticoidsROACH ALAN GEOFFREY·Filed 2007·Application pending·0 cites
- 2536US2006193776A1Screening methods employing zebrafish and the blood brain barrierGOLDSMITH PAUL·Filed 2005·Application pending·0 cites
- 2636US2020345299A1Monitoring Patient Compliance with a Dosage RegimenCLOSED LOOP MEDICINE LTD·Filed 2020·Application pending·0 cites
- 2735US2023118099A1Personalised Medicine Treatment ProgramCLOSED LOOP MEDICINE LTD·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Paul Goldsmith files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →